✦ LIBER ✦

9150 POSTER Testing Practices for EGFR and KRAS in Advanced Non-small Cell Lung Cancer in a Comprehensive Cancer Care Setting in Korea

✍ Scribed by Choi, Y.; Han, J.; Cho, J.; Guallar, E.; Parasuraman, B.; Lee, G.; Park, K.; Lee, J.; Sun, J.; Shim, Y.M.

Book ID: 122889662
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)72462-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9115 POSTER Pattern of Chemotherapy for

9115 POSTER Pattern of Chemotherapy for Advanced Non-small Cell Lung Cancer in Relation to EGFR Mutation Status – Clinical Experience in a Comprehensive Cancer Center in Korea

✍ Park, K.; Lee, J.; Sun, J.; Cho, J.; Guallar, E.; Parasuraman, B.; Lee, G.; Han, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

KRAS mutations in non-small-cell lung ca

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

✍ Maus, M.K.H.; Grimminger, P.P.; Mack, P.C.; Astrow, S.H.; Stephens, C.; Zeger, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Advances in anti-VEGF and anti-EGFR ther

Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer

✍ Reck, Martin; Crinò, Lucio 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Routine EGFR and KRAS Mutation analysis

Routine EGFR and KRAS Mutation analysis using COLD-PCR in non-small cell lung cancer

✍ A. Pennycuick; T. Simpson; D. Crawley; R. Lal; G. Santis; P. Cane; K. Tobal; J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

A Multicenter Blinded Study Evaluating E

A Multicenter Blinded Study Evaluating EGFR and KRAS Mutation Testing Methods in the Clinical Non–Small Cell Lung Cancer Setting—IFCT/ERMETIC2 Project Part 1

✍ Beau-Faller, Michèle; Blons, Hélène; Domerg, Caroline; Gajda, Dorota; Richard, N 📂 Article 📅 2014 🏛 American Society for Investigative Pathology 🌐 English ⚖ 612 KB

Can mutations of EGFR and KRAS in serum

Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?

✍ Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Kyong Hwa Park, Sang Won Shin, Yeul Ho 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 300 KB